Gunnar Brobert

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.

Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.

Journal: Journal of thrombosis and thrombolysis

Published: April 26, 2024

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Journal: BMJ open

Published: March 26, 2024

Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study.

Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study.

Journal: Thrombosis and haemostasis

Published: February 01, 2024

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program.

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: August 16, 2023

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

Journal: PloS one

Published: July 05, 2023

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding.

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: March 03, 2023

Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults.

Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults.

Journal: BMC nephrology

Published: February 23, 2023

Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.

Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.

Journal: Expert opinion on drug safety

Published: February 16, 2023

CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research.

CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research.

Journal: BMJ (Clinical research ed.)

Published: December 23, 2022

Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.

Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.

Journal: Drugs - real world outcomes

Published: December 13, 2022

Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom.

Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom.

Journal: Clinical epidemiology

Published: July 27, 2022

CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research.

CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research.

Journal: The Lancet. Digital health

Published: July 14, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026